Proaño NJ, Aguilar RF

Language: Spanish
References: 20
Page: 95-105
PDF size: 188.38 Kb.

ABSTRACT

Increase of word population average life span is accompanied by increment of against associated pathology.
The dementia is clinically characterized by alterations of cognition memory problems in short term memory, orientation, calculation and judgment, etc, progressive and association with motor control, behavior and personality changes. Diagnosis include neurological evaluation motor, cognition and laboratory.
Fortunately, technological advances allow early diagnosis through non-invasive, Neuroimaging methods. Morphological and functional information of the normal or pathological brain is obtainer. These data are useful in diagnosing several types of dementia (Alzheimer’s vascular, fronto-temporal, AIDS, dementia complex, etc.). “Treatable causes of dementia” are detected with these procedures, such as chronic subdural hematoma, normal pressure hydrocephalus, depression, primary tumors and brain metastatic illness. Functional images offer neurochemical information about certain brain metabolites, which are helpful in differential diagnosis of several others CNS illnesses with signs or symptoms similar to dementia. Neurophatological studies are de gold standard to observe neurofibrilary tangles and amiloid plaques.

REFERENCES

1. Katzman R, Terri R. Normal aging of the nervous system. In: Katzman R, Terri RD. The neurology of aging. Philadelphia, F. A. Davis, 1983:15-50.

2. Beck J, Benson F, Scheibel A et al. Dementia in the elderly: the silent epidemic. Ann Int Med 1982;97: 231-241.

3. García JH, Brown GG. Vascular dementia: neuropathologic and metabolic brain changes. J Neurol Sci 1992;109:121-131.

4. Amaducci LA, Rocca WA, Schoenberg BS. Origin of the distinction between Alzheimer’s disease and senile dementia: how history can clarify nosology. Neurology 1986;1:497-499.

5. Schoenberg BS. Epidemiology of dementia. Neurol Clin 1986;4:447-457.

6. McKhann G, Drachman D, Flostein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA Work Group under the auspice of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939-944.

7. Iversen LL. The cholinergic hypothesis of dementia. TINS 1986;2(Suppl):44-45.

8. Harrison PJ. Pathogenesis of Alzheimer’s disease beyond the cholinergic hypothesis. J Royal Soc Med 1986;79: 347-352.

9. Quinn NP, Rosser MN, Marsden CD. Dementia and Parkinson’s disease: pathological and neurochemical considerations. Br Med Bull 1988;42:263-287.

10. Whitehouse PJ. The concept of subcortical dementia: another look. Ann Neurol 1986;19:1-6.

11. Brown RG, Marsden CD. Subcortical dementia: the neuropsychological evidence. Neuroscience 1988; 25:263-287.

12. Salzman C, Shader RI. Depression in the elderly. I. Relationship between depression, psychologic defense mechanisms and physical illness. J Am Geriatric Soc 1978;26:303-308.

13. Marin SM-O. Aging and dementias. A diagnostic, therapeutic and social challenge. Curso para Fellows en Neurociencias. Good Samaritan Hospital, Portland, Oregon, EUA, 1987.

14. Selkoe DJ. Biochemistry of altered brain proteins in Alzheimer’s disease. Ann Rev Neurosci 1989;12:493-520.

15. Creasey H, Rapoport SI. The aging human brain. Ann Neurol 1985;17:2-10.

16. Barnes DM. Defect in Alzheimer’s disease. Is on chromosome 21? Science 1987;235:846-847.

17. Giuseppe B, Morh E, Gillespie M et al. Muscarinic agonist of Alzheimer’s disease. A clinical trial of RS 86. Arch Neurol 1986;43:659-661.

18. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med 1988;109:476-486.

19. Mayeux R, Saunders A, Shea S, Mirra S, Evans D et al. Utility of the apoliprotein e genotype in the diagnosis of Alzheimer’s Disease. N Engl J Med 1998;338:506-11.

20. Mayeux R, Sano M. Treatment of Alzheimer’s Disease. N Engl J Med 1999;341:1670-1679.